ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,843Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 15

$522K Total Retail Price of All Prescriptions

Rank: 4 out of 15

469 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 15%.

Schedule Three
Controlled Substances

3% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 10,250 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
FUROSEMIDE 581 581 1 2
WARFARIN SODIUM 566 530 2 1
METOPROLOL TARTRATE 442 422 3 4
POLYETHYLENE GLYCOL 3350 396 339 4 20
LEVOTHYROXINE SODIUM 344 343 5 3
OMEPRAZOLE 335 323 6 8
LISINOPRIL 325 313 7 6
IPRATROPIUM-ALBUTEROL 267 267 8 39
MIRTAZAPINE 263 259 9 12
TRAZODONE HCL 261 235 10 16
TRAMADOL HCL 254 246 11 10
SIMVASTATIN 253 253 12 7
CITALOPRAM HBR 236 232 13 13
KLOR-CON M20 205 179 14 36
AMLODIPINE BESYLATE 164 164 15 11
SERTRALINE HCL 162 147 16 5
DONEPEZIL HCL 157 146 17 9
METOPROLOL SUCCINATE 149 149 18 14
LANTUS 144 127 19 21
CARBIDOPA-LEVODOPA 129 129 20 43
GABAPENTIN 109 108 21 18
HYDROCHLOROTHIAZIDE 103 103 22 37
ADVAIR DISKUS 103 102 22 24
ATORVASTATIN CALCIUM 100 82 24 23
CYMBALTA 100 75 24 28
SPIRIVA 97 96 26 22
LIDODERM 97 97 26 30
ESCITALOPRAM OXALATE 93 92 28 38
POTASSIUM CHLORIDE 92 92 29 19
NAMENDA 89 64 30 17
GLIPIZIDE 84 84 31 44
CIPROFLOXACIN HCL 73 70 32 53
OLANZAPINE 70 70 33 40
PREDNISONE 70 70 33 35
ATENOLOL 65 62 35 33
HYDRALAZINE HCL 63 63 36 70
TAMSULOSIN HCL 63 47 36 29
TRIAMCINOLONE ACETONIDE 61 61 38 92
LOSARTAN POTASSIUM 60 60 39 56
ISOSORBIDE MONONITRATE ER 60 60 39 26
DIVALPROEX SODIUM 57 57 41 34
ROPINIROLE HCL 57 57 41 69
PANTOPRAZOLE SODIUM 56 56 43 55
SPIRONOLACTONE 56 56 43 46
LEXAPRO 56 56 43 100
KLOR-CON M10 54 53 46 62
VENLAFAXINE HCL ER 54 54 46 54
QUETIAPINE FUMARATE 53 53 48 31
BUMETANIDE 52 52 49 74
RISPERIDONE 50 50 50 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.